No Benefit of BCR-ABL1 Screening in
Polycythemia
Published: July 1, 2016 | DOI: https://doi.org/10.7860/JCDR/2016/.8176
Stephen E. Langabeer
1. Clinical Scientist, Cancer Molecular Diagnostics, St. James’s Hospital, Dublin, Ireland.
Correspondence
Dr. Stephen E. Langabeer,
Cancer Molecular Diagnostics, Central Pathology Laboratory
St. James’s Hospital, Dublin 8, Ireland.
E-mail: slangabeer@stjames.ie
[
FULL TEXT ] | [ PDF]